Periodontal disease and breast cancer: Prospective cohort study of postmenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 1, 2016, Pages 43-50

  Freudenheim, Jo L ^a   Genco, Robert J ^a   LaMonte, Michael J ^a   Millen, Amy E ^a   Hovey, Kathleen M ^a   Mai, Xiaodan ^a   Nwizu, Ngozi ^b   Andrews, Christopher A ^c   Wactawski Wende, Jean ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BREAST NEOPLASMS; CANCER STAGING; COMPLICATION; FEMALE; FOLLOW UP; HUMAN; MIDDLE AGED; PERIODONTAL DISEASE; POSTMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDY; TUMOR INVASION; WOMEN'S HEALTH;

AGED; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERIODONTAL DISEASES; POSTMENOPAUSE; PROGNOSIS; PROSPECTIVE STUDIES; WOMEN'S HEALTH;

EID: 84955308916     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0750     Document Type: Article

References (56)

1. Linden GJ, Herzberg MC and on behalf of working group 4 of the joint EFP/AAP workshop. Periodontitis and systemic diseases: a record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Periodontol 2013;84:S20-3.
2. Andriankaja O, Trevisan M, Falkner K, Dorn J, Hovey K, Sarikonda S, et al. Association between periodontal pathogens and risk of nonfatal myocardial infarction. Community Dent Oral Epidemiol 2011;39:177-85.
3. Humphrey LL, Fu R, Buckley DI, Freeman M, Helfand M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med 2008;23:2079-86.
4. Janket S-J, Baird AE, Chuang S-K, Jones JA. Meta-analysis of periodontal disease and risk of coronary heart disease and stroke. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003;95:559-69.
5. Gurav A, Jadhav V. Periodontitis and risk of diabetes mellitus. J Diabetes 2011;3:21-8.
6. Fitzpatrick SG, Katz J. The association between periodontal disease and cancer: a review of the literature. J Dentistry 2010;38:83-95.
7. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012;33:1055-8.
8. Linden GJ, Lyons A, Scannapieco FA. Periodontal systemic associations: review of the evidence. J Clin Periodontol 2013;84:S8-19.
9. Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, et al. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013;62:1764-70.
10. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2009;18:2406-12.
11. Hujoel PP, Drangsholt M, Spiekerman C, Weiss NS. An exploration of the periodontitis-cancer association. Ann Epidemiol 2003;13:312-6.
12. Arora M, Weuve J, Fall K, Pedersen NL, Mucci LA. An exploration of shared genetic risk factors between periodontal disease and cancers: a prospective co-twin study. Am J Epidemiol 2010;171:253-9.
13. Söder B, Yakob M, Meurman JH, Andersson LC, Klinge B, Söder P-O. Periodontal disease may associate with breast cancer. Breast Cancer Res Treat 2011;127:497-502.
14. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
15. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol 2003;13:S18-77.
16. Anderson GL, Manson JE, Wallace R, Lund B, Hall D, Davis S, et al. Implementation of the Women's Health Initiative Study Design. Ann Epidemiol 2003;13:S5-17.
17. Langer RD, White E, Lewis CE, Kotchen JM, Hendrix SL, Trevisan M. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol 2003;13:S107-21.
18. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, et al. Outcomes ascertainment and adjudication in the Women's Health Initiative. Ann Epidemiol 2003;13:S122-8.
19. Ries LAGMD, Karpcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, et al. SEER cancer statistics review, 1975-2004. Bethesda, MD: National Cancer Institute, 2007.
20. LaMonte MJ, Hovey KM, Millen AE, Genco RJ, Wactawski-Wende J. Accuracy of self-reported periodontal disease in the Women's Health Initiative Observational Study. J Periodontol 2014;85:1006-18.
21. US Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2004.
22. Bizzarro S, Loos BG, Laine ML, Crielaard W, Zaura E. Subgingival microbiome in smokers and non-smokers in periodontitis: an exploratory study using traditional targeted techniques and a next-generation sequencing. J Clin Periodontol 2013;40:483-92.
23. van Winkelhoff AJ, Bosch-Tijhof CJ, Winkel EG, can der Reijden WA. Smoking affects the subgingival microflora in periodontitis. J Peridontol 2001;72:666-71.
24. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998.
25. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-9.
26. Luo J, Margolis KL, Wactawski-Wende J, Horn K, Messina C, Stefanick ML, et al. Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ 2011;342:d1016.
27. Van Dyke TE, van Winkelhoff AJ. Infection and inflammatory mechanisms. J Periodontol 2013;84:S1-7.
28. Tomas I, Diz P, Tobias A, Scully C, Donos N. Periodontal health status and bacteraemis from daily oral activities: systematic review/meta-analysis. J Clin Periodontol 2012;39:213028.
29. Ward TL, Hosid S, Ioshikhes I, Altosaar I. Human milk metagneome: a functional capacity analysis. BMC Microbiol 2013;13:116.
30. Fernandez L, Langa S, Martin V, Mardonado A, Jimenez E, Martin R, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res 2013;69:1-10.
31. Michie CA, Gilmour J. Breastfeeding and the risks of viral transmission. Arch Dis Child 2001;84:381-2.
32. Urbaniak C, Burton JP, Reid G. Breast, milk and microbes: a complex relationship that does not end with lactation. Womens Health 2012;8:385-98.
33. Urbaniak C, Cummins J, Brackstone M, Macklaim JM, Gloor GB, Baban CK, et al. Microbiota of human breast tissue. Appl Environ Microbiol 2014;80:3007-14.
34. Xuan C, Shamonki JM, Chung A, Dinome ML, Chung M, Sieling PA, et al. Microbial dysbiosis is associated with human breast cancer. PLoS ONE 2014;9:e83744.
35. Velicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH. Antibiotic use in relation to the risk of breast cancer. JAMA 2004;291:827-35.
36. Kikkinen A, Rissanen H, Klaukka T, Pukkala E, Heliovaara M, Huovinen P, et al. Antibiotics use predicts an increased risk of cancer. Int J Cancer 2008;123:2152-5.
37. Friedman GD, Oestreicher N, Chan J, Quesenberry CP, Udaltsova N, Habel LA. Antibiotics and risk of breast cancer: up to 9 years of follow-up of 2.1 million women. Cancer Epidemiol Biomarkers Prev 2006;15:2102-6.
38. Sorenson HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case control study. Br J Cancer 2005;92:594-6.
39. Rodriguez LAG, Gonzalez-Perez A. Use of antibiotics and risk of breast cancer. Am J Epidemiol 2005;161:616-9.
40. Chan DS, Bandera EV, Greenwood DC, Norat T. Circulating c-reactive protein and breast cancer risk - systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol Biomarkers Prev 2015;24:1439-49.
41. Joshipura KJ, Wand HC, Merchant AT, Rimm EB. Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res 2004;83:151-5.
42. Noack B, Genco RJ, Trevisan M, Gross S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-7.
43. Hayashi C, Gudino CV, Gibson FC, Genco CA. Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010;25:305-16.
44. Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13:759-71.
45. Schwabe RF, Jobin C. The microbiome and cancer. Nat Rev Cancer 2013;13:800-12.
46. Soory M. Oxidative stress induced mechanisms in the progression of periodontal disease and cancer: a common approach to redox homeostasis? Cancers 2010;2:670-92.
47. Miricescu D, Greabu M, Totan A, Mohora M, Didilescu A, Mitrea N, et al. Oxidative stress - a possible link between systemic and oral diseases. Farmacia 2011;59:329-37.
48. Bartold PM, Van Dyke TE. Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts. Periodontol 2000 2013;62:203-18.
49. Gonzalez-Suarez E, Jacob AP, Jones J, Miller R, Roudier-Meyer MP, Erwert R, et al. Rank ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis. Nature 2010;468:103-7.
50. Schramek D, Leibbrandt A, Sigl V, Kenner L, Pospislik JA, Lee HJ, et al. Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer. Nature 2010;468:98-102.
51. Sigl V, Penninger JM. RANKL/RANK-From bone physiology to breast cancer. Cytokine Growth Factor Rev 2014;25:205-14.
52. Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, et al. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006;440:692-6.
53. Belibasakis GN, Bostanci N. The RANKL-OPG system in clinical periodontology. J Clin Periodontol 2012;39:239-48.
54. Tobon-Arroyave SI, Isaza-Guzman DM, Restrepo-Cadavid EM, Zapata-Molina SM, Martinez-Pabon MC. Association of salivary levels of the bone remodeling regulators sRANKL and OPG with periodontal clinical status. J Clin Periodontol 2012;39:1132-40.
55. Shchipkova AY, Nagaraja HN, Kumar PS. Subgingival microbialprofiles of smokers with periodontitis. J Dent Res 2010;89:1246-53.
56. Michaud D, Izard J, Rubin Z, Johansson I, Weiderpass E, Tjonneland A, et al. Lifestyle, dietary factors and antibody levels to oral bacteria in cancer-free participants in a European cohort study. Cancer Causes Control 2013;24:1901-9.